Tumor-Associated Macrophages in Hepatocellular Carcinoma: Friend or Foe?

Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide, and it has diverse etiologies with multiple mechanisms. The diagnosis of HCC typically occurs at advanced stages when there are limited therapeutic options. Hepatocarcinogenesis is considered a multistep process, and he...

Full description

Bibliographic Details
Published in:	Gut and Liver
Main Authors:	Dexi Zhou, Jiajie Luan, Cheng Huang, Jun Li
Format:	Article
Language:	English
Published:	Gastroenterology Council for Gut and Liver 2021-07-01
Subjects:	hepatocellular carcinoma tumor-associated macrophages macrophage polarization epigenetic modification cancer therapy
Online Access:	http://gutnliver.org/journal/view.html?doi=10.5009/gnl20223

Similar Items

The dual role of CXCL9/SPP1 polarized tumor-associated macrophages in modulating anti-tumor immunity in hepatocellular carcinoma
by: Yu Gu, et al.
Published: (2025-03-01)

Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma
by: Pil Soo Sung
Published: (2022-07-01)

Tumor-Associated Macrophages Affect the Tumor Microenvironment and Radioresistance via the Upregulation of CXCL6/CXCR2 in Hepatocellular Carcinoma
by: Hsin-Lun Lee, et al.
Published: (2023-07-01)

Epigenetic tuning of tumour-associated macrophages (TAMs): a potential approach in hepatocellular carcinoma (HCC) immunotherapy
by: Israa M. Helal, et al.
Published: (2024-01-01)

Tissue‐Resident Macrophages in Cancer: Friend or Foe?
by: Jianhua Chi, et al.
Published: (2024-11-01)

CD63 + tumor-associated macrophages drive the progression of hepatocellular carcinoma through the induction of epithelial-mesenchymal transition and lipid reprogramming
by: Shiqi Liu, et al.
Published: (2024-06-01)

Crosstalk between exosomes and tumor-associated macrophages in hepatocellular carcinoma: implication for cancer progression and therapy
by: Ying Xu, et al.
Published: (2025-04-01)

Tumor-associated macrophages modulate resistance to oxaliplatin via inducing autophagy in hepatocellular carcinoma
by: Xiu-Tao Fu, et al.
Published: (2019-03-01)

Role of tumor-associated macrophages in hepatocellular carcinoma: impact, mechanism, and therapy
by: Yinqi Zhang, et al.
Published: (2024-08-01)

The role of tumor‐associated macrophages in hepatocellular carcinoma progression: A narrative review
by: Xinyi Zhang, et al.
Published: (2023-12-01)

Galectin‐1‐Induced Tumor Associated Macrophages Repress Antitumor Immunity in Hepatocellular Carcinoma Through Recruitment of Tregs
by: Xizhi Yu, et al.
Published: (2025-03-01)

Histone modifications and metabolic reprogramming in tumor-associated macrophages: a potential target of tumor immunotherapy
by: Yiting Xu, et al.
Published: (2025-05-01)

Mechanisms of tumor-associated macrophages affecting the progression of hepatocellular carcinoma
by: Yi Yuan, et al.
Published: (2023-08-01)

Meta-Analysis of the Prognostic and Clinical Value of Tumor-Associated Macrophages in Hepatocellular Carcinoma
by: Jie Zhang, et al.
Published: (2021-03-01)

Targeting tumor-associated macrophages to overcome immune checkpoint inhibitor resistance in hepatocellular carcinoma
by: Fen Liu, et al.
Published: (2025-08-01)

Identification of SPP1+ macrophages as an immune suppressor in hepatocellular carcinoma using single-cell and bulk transcriptomics
by: Han Jin, et al.
Published: (2024-12-01)

Tumor-Associated Macrophages in Oncolytic Virotherapy: Friend or Foe?
by: Nicholas L. Denton, et al.
Published: (2016-07-01)

The Role of Innate Priming in Modifying Tumor-associated Macrophage Phenotype
by: Ben Topham, et al.
Published: (2024-12-01)

PD-L1(+) tumor-associated macrophages induce CD8(+) T Cell exhaustion in hepatocellular carcinoma
by: Takuto Nosaka, et al.
Published: (2025-11-01)

Reprogramming tumor-associated macrophages and inhibiting tumor neovascularization by targeting MANF–HSF1–HSP70-1 pathway: An effective treatment for hepatocellular carcinoma
by: Dan Han, et al.
Published: (2024-10-01)

Tumor−associated macrophage polarization in the inflammatory tumor microenvironment
by: Zijuan Zou, et al.
Published: (2023-02-01)

Macrophage metabolism, phenotype, function, and therapy in hepatocellular carcinoma (HCC)
by: Jingquan Huang, et al.
Published: (2023-11-01)

Construction of a Prognostic Model for Hepatocellular Carcinoma Based on Macrophage Polarization-Related Genes
by: Chen H, et al.
Published: (2024-05-01)

GPER1 signaling restricts macrophage proliferation and accumulation in human hepatocellular carcinoma
by: Yanyan Yang, et al.
Published: (2024-11-01)

INKA2-AS1 promotes migration, invasion and macrophage-related immunosuppression in hepatocellular carcinoma
by: HE Xiutang, et al.
Published: (2025-09-01)

Progress in reeducating tumor-associated macrophages in tumor microenvironment
by: Yiming Zhao, et al.
Published: (2024-07-01)

Reprogramming tumor-associated macrophages in gastric cancer: a pathway to enhanced immunotherapy
by: Yibo He, et al.
Published: (2025-03-01)

Hepatocellular carcinoma and AIM2: Therapeutic potential through regulation of autophagy and macrophage polarization
by: Shuangshuang Xie, et al.
Published: (2024-09-01)

SPP1+ tumor-associated macrophages define a high-risk subgroup and inform personalized therapy in hepatocellular carcinoma
by: Wei-Xuan Xu, et al.
Published: (2025-07-01)

Tumor-associated macrophages in bladder cancer: roles and targeted therapeutic strategies
by: Yuanchun Ma, et al.
Published: (2024-11-01)

β,β-Dimethylacrylalkannin, a Natural Naphthoquinone, Inhibits the Growth of Hepatocellular Carcinoma Cells by Modulating Tumor-Associated Macrophages
by: Li-Sha Shen, et al.
Published: (2024-08-01)

Hepatocellular carcinoma-derived FOXO1 inhibits tumor progression by suppressing IL-6 secretion from macrophages
by: Xiao Cui, et al.
Published: (2023-06-01)

Influencing Factors and Significance of Tumor-associated Macrophage Polarization  in Tumor Microenvironment
by: Wenke GE, et al.
Published: (2023-03-01)

Sono-Immunotherapy Mediated Controllable Composite Nano Fluorescent Probes Reprogram the Immune Microenvironment of Hepatocellular Carcinoma
by: Chen Y, et al.
Published: (2023-10-01)

Significance of infiltration of M1 tumor-associated macrophages in hepatocellular carcinoma
by: XIAO Feng, XU Tonglin, ZHU Lin, XIAO Jingwen, WU Tianqi, GU Chunyan
Published: (2024-08-01)

Periplocin improves the sensitivity of oxaliplatin-resistant hepatocellular carcinoma cells by inhibiting M2 macrophage polarization
by: Jiefeng Weng, et al.
Published: (2024-08-01)

Bacteria and macrophages in the tumor microenvironment
by: Shiyao Xu, et al.
Published: (2023-02-01)

Tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for hepatocellular carcinoma: recent research progress
by: Ziwei Li, et al.
Published: (2024-06-01)

Histological perspective on the effects of tumor-associated macrophages in the tumor microenvironment surrounding papillary thyroid carcinoma
by: Nuray Y. Can, et al.
Published: (2017-02-01)

The role of tumor-associated macrophages in the progression, prognosis and treatment of endometrial cancer
by: Yihan Sun, et al.
Published: (2023-09-01)